| # | Drug | Count |
|---|---|---|
| 0 | SIMVASTATIN | 4 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | CLOZAPINE | 3 |
| 3 | ACETAMINOPHEN 500MG | 2 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | METOCLOPRAMIDE HYDROCHLORIDE | 2 |
| 7 | NINTEDANIB | 2 |
| 8 | PAIN RELIEVER | 2 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0.0010 |
| 1 | IDURSULFASE | 1 | 0.0003 |
| 2 | DIMENHYDRINATE | 1 | 0.0001 |
| 3 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 1 | 0.0001 |
| 4 | REGORAFENIB | 1 | 0.0001 |
| 5 | CORTISONE ACETATE | 1 | 0.0001 |
| 6 | LOPERAMIDE HCL | 1 | 0.0001 |
| 7 | TOLVAPTAN | 1 | 0.0001 |
| 8 | NINTEDANIB | 2 | 0.0001 |
| 9 | POSACONAZOLE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 4 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 2 |
| 3 | Loop Diuretic [EPC] | 2 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 5 | Proton Pump Inhibitor [EPC] | 2 |
| 6 | Antimetabolite [EPC] | 1 |
| 7 | Antirheumatic Agent [EPC] | 1 |
| 8 | Aromatase Inhibitor [EPC] | 1 |
| 9 | Azole Antifungal [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |
| 4 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 5 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 4 | 0.0000 |